News
In most cases, the complications are due to ischemic optic neuropathy. In a cohort of 161 Spanish patients with biopsy-proven GCA, 26% experienced visual symptoms.
Prognosis & Outcome In one study of 161 patients with biopsy-proven GCA followed up for 11 years, the prevalence of visual ischemic complications was 26.1% and the prevalence of irreversible ...
NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.
Background: Giant cell arteritis (GCA) is a granulomatous vasculitis in older individuals that primarily affects medium-to-large vessels. Owing to the involvement of the ophthalmic arteries, GCA can ...
A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...
Upadacitinib 15 mg — but not 7.5 mg — alongside a glucocorticoid taper demonstrated superior efficacy to placebo with a ...
Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...
13d
News-Medical.Net on MSNCommon autoimmune drug shown to help patients with giant cell arteritisA common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...
“While the phase 3 results of GCAptAIN did not replicate the positive outcomes observed in the phase 2 trial, we remain committed to continuing to drive scientific progress and deepening the ...
Novartis (NYSE:NVS) (OTCPK:NVSEF) announced Thursday that its FDA-approved anti-inflammatory agent Cosentyx failed to reach ...
In the 2004 Bowman Lecture, I give a panegyric for Sir William Bowman, an estimate of the importance and the epidemiology of anterior visual pathway developmental disorders, followed by a history ...
5d
Zacks Investment Research on MSNNovartis' Cosentyx Misses Primary Goal in Arteritis Phase III StudyNovartis NVS announced that a late-stage study of its interleukin-17A inhibitor, Cosentyx (secukinumab), has failed to meet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results